Nabiey Romin has filed 143 insider transactions across 1 company since January 2023.
Most recent transaction: a tax payment of 4201 shares of GoodRx Holdings, Inc. ($GDRX) on March 08, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4201 | $2.28 | 181,748.0000 | 361,423,000 | 2.26% | 0.00% |
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 185,949.0000 | 361,423,000 | 5.80% | 0.00% |
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2233 | $0.00 | 17,858.0000 | 361,423,000 | 11.11% | 0.00% |
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 20,402.0000 | 361,423,000 | 33.33% | 0.00% |
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 920 | $2.28 | 183,061.0000 | 361,423,000 | 0.50% | 0.00% |
| March 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2233 | $0.00 | 183,981.0000 | 361,423,000 | 1.23% | 0.00% |
| March 3, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Restricted Stock Unit | 108189 | $0.00 | 108,189.0000 | 361,423,000 | 9999.99% | 0.03% |
| Feb. 15, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1979 | $2.18 | 175,748.0000 | 361,423,000 | 1.11% | 0.00% |
| Feb. 15, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 4804 | $0.00 | 57,650.0000 | 361,423,000 | 7.69% | 0.00% |
| Feb. 15, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 4804 | $0.00 | 177,727.0000 | 361,423,000 | 2.78% | 0.00% |
| Feb. 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 178,138.0000 | 361,423,000 | 7.65% | 0.00% |
| Feb. 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 5215 | $2.44 | 172,923.0000 | 361,423,000 | 2.93% | 0.00% |
| Feb. 8, 2026 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 63,314.0000 | 361,423,000 | 16.67% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3650 | $2.71 | 164,042.0000 | 361,423,000 | 2.18% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 799 | $2.71 | 165,475.0000 | 361,423,000 | 0.48% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10200 | $0.00 | 30,603.0000 | 361,423,000 | 25.00% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 20,091.0000 | 361,423,000 | 10.00% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10200 | $0.00 | 167,692.0000 | 361,423,000 | 6.48% | 0.00% |
| Dec. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 166,274.0000 | 361,423,000 | 1.36% | 0.00% |
| Nov. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 4804 | $0.00 | 62,454.0000 | 361,423,000 | 7.14% | 0.00% |
| Nov. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 4804 | $0.00 | 158,211.0000 | 361,423,000 | 3.13% | 0.00% |
| Nov. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1719 | $2.97 | 156,492.0000 | 361,423,000 | 1.09% | 0.00% |
| Nov. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12662 | $0.00 | 75,977.0000 | 361,423,000 | 14.28% | 0.00% |
| Nov. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4531 | $3.11 | 153,407.0000 | 361,423,000 | 2.87% | 0.00% |
| Nov. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12662 | $0.00 | 157,938.0000 | 361,423,000 | 8.72% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 147,493.0000 | 392,172,000 | 7.43% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 22,323.0000 | 392,172,000 | 9.09% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 799 | $4.00 | 145,276.0000 | 392,172,000 | 0.55% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 40,803.0000 | 392,172,000 | 20.00% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 146,075.0000 | 392,172,000 | 1.55% | 0.00% |
| Sept. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3650 | $4.00 | 143,843.0000 | 392,172,000 | 2.47% | 0.00% |
| Aug. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1719 | $3.54 | 137,292.0000 | 392,172,000 | 1.24% | 0.00% |
| Aug. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 4804 | $0.00 | 139,011.0000 | 392,172,000 | 3.58% | 0.00% |
| Aug. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 4804 | $0.00 | 67,258.0000 | 392,172,000 | 6.67% | 0.00% |
| Aug. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 88,639.0000 | 392,172,000 | 12.50% | 0.00% |
| Aug. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4531 | $3.47 | 134,207.0000 | 392,172,000 | 3.27% | 0.00% |
| Aug. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 138,738.0000 | 392,172,000 | 10.04% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 24,555.0000 | 392,172,000 | 8.33% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3650 | $4.08 | 124,642.0000 | 392,172,000 | 2.85% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 799 | $4.08 | 126,075.0000 | 392,172,000 | 0.63% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 51,004.0000 | 392,172,000 | 16.67% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 126,874.0000 | 392,172,000 | 1.79% | 0.00% |
| June 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 128,292.0000 | 392,172,000 | 8.64% | 0.00% |
| May 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 4804 | $0.00 | 72,062.0000 | 392,172,000 | 6.25% | 0.00% |
| May 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 4804 | $0.00 | 119,810.0000 | 392,172,000 | 4.18% | 0.00% |
| May 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1719 | $4.27 | 118,091.0000 | 392,172,000 | 1.43% | 0.00% |
| May 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 101,302.0000 | 392,172,000 | 11.11% | 0.00% |
| May 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 119,537.0000 | 392,172,000 | 11.85% | 0.00% |
| May 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4531 | $3.79 | 115,006.0000 | 392,172,000 | 3.79% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4191 | $4.61 | 105,449.0000 | 392,172,000 | 3.82% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 109,640.0000 | 392,172,000 | 10.26% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2233 | $0.00 | 26,787.0000 | 392,172,000 | 7.69% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 61,205.0000 | 392,172,000 | 14.29% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 808 | $4.61 | 106,874.0000 | 392,172,000 | 0.75% | 0.00% |
| March 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2233 | $0.00 | 107,682.0000 | 392,172,000 | 2.12% | 0.00% |
| March 5, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Restricted Stock Unit | 76866 | $0.00 | 76,866.0000 | 392,172,000 | 9999.99% | 0.02% |
| March 5, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Stock Option (Right to Buy) | 114507 | $0.00 | 114,507.0000 | 392,172,000 | 9999.99% | 0.03% |
| Feb. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12662 | $0.00 | 113,965.0000 | 392,172,000 | 10.00% | 0.00% |
| Feb. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 5202 | $4.84 | 99,439.0000 | 392,172,000 | 4.97% | 0.00% |
| Feb. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12662 | $0.00 | 104,641.0000 | 392,172,000 | 13.77% | 0.00% |
| Jan. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 0.0000 | 392,172,000 | 100.00% | 0.00% |
| Jan. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1071 | $4.15 | 91,979.0000 | 392,172,000 | 1.15% | 0.00% |
| Jan. 15, 2025 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 93,050.0000 | 392,172,000 | 2.88% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3640 | $4.91 | 89,009.0000 | 393,477,000 | 3.93% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10200 | $0.00 | 92,649.0000 | 393,477,000 | 12.37% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 91,241.0000 | 393,477,000 | 2.51% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10200 | $0.00 | 71,406.0000 | 393,477,000 | 12.50% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 797 | $4.91 | 90,444.0000 | 393,477,000 | 0.87% | 0.00% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 29,020.0000 | 393,477,000 | 7.14% | 0.00% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 126,627.0000 | 393,477,000 | 9.09% | 0.00% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4519 | $5.04 | 82,449.0000 | 393,477,000 | 5.20% | 0.00% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 86,968.0000 | 393,477,000 | 17.04% | 0.00% |
| Oct. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 930 | $6.91 | 74,305.0000 | 393,477,000 | 1.24% | 0.00% |
| Oct. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 2,606.0000 | 393,477,000 | 50.00% | 0.00% |
| Oct. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 75,235.0000 | 393,477,000 | 3.59% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 81,606.0000 | 410,315,000 | 11.11% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 31,252.0000 | 410,315,000 | 6.67% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 797 | $7.71 | 72,629.0000 | 410,315,000 | 1.09% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 73,426.0000 | 410,315,000 | 3.14% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3640 | $7.71 | 71,194.0000 | 410,315,000 | 4.86% | 0.00% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 74,834.0000 | 410,315,000 | 15.78% | 0.00% |
| Aug. 12, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | S | Class A Common Stock | 79000 | $6.77 | 64,633.0000 | 410,315,000 | 55.00% | 0.02% |
| Aug. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 148,152.0000 | 410,315,000 | 9.35% | 0.00% |
| Aug. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4519 | $8.61 | 143,633.0000 | 410,315,000 | 3.05% | 0.00% |
| Aug. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 139,290.0000 | 410,315,000 | 8.33% | 0.00% |
| July 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 5,212.0000 | 410,315,000 | 33.33% | 0.00% |
| July 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 930 | $7.71 | 135,489.0000 | 410,315,000 | 0.68% | 0.00% |
| July 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 136,419.0000 | 410,315,000 | 1.95% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 797 | $8.55 | 133,813.0000 | 410,315,000 | 0.59% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 136,018.0000 | 410,315,000 | 8.11% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3640 | $8.55 | 132,378.0000 | 410,315,000 | 2.68% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2232 | $0.00 | 134,610.0000 | 410,315,000 | 1.69% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 91,807.0000 | 410,315,000 | 10.00% | 0.00% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2232 | $0.00 | 33,484.0000 | 410,315,000 | 6.25% | 0.00% |
| May 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12662 | $0.00 | 130,335.0000 | 410,315,000 | 10.76% | 0.00% |
| May 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12662 | $0.00 | 151,953.0000 | 410,315,000 | 7.69% | 0.00% |
| May 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4518 | $7.53 | 125,817.0000 | 410,315,000 | 3.47% | 0.00% |
| April 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 7,818.0000 | 410,315,000 | 25.00% | 0.00% |
| April 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 930 | $6.83 | 117,673.0000 | 410,315,000 | 0.78% | 0.00% |
| April 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 118,603.0000 | 410,315,000 | 2.25% | 0.00% |
| March 12, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Restricted Stock Unit | 35716 | $0.00 | 35,716.0000 | 410,315,000 | 9999.99% | 0.01% |
| March 12, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Stock Option (Right to Buy) | 51462 | $0.00 | 51,462.0000 | 410,315,000 | 9999.99% | 0.01% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3745 | $7.54 | 115,997.0000 | 410,315,000 | 3.13% | 0.00% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 102,008.0000 | 410,315,000 | 9.09% | 0.00% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 119,742.0000 | 410,315,000 | 9.31% | 0.00% |
| Feb. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 114,731.0000 | 410,315,000 | 12.41% | 0.00% |
| Feb. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 5190 | $6.22 | 109,541.0000 | 410,315,000 | 4.52% | 0.00% |
| Feb. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 164,615.0000 | 410,315,000 | 7.14% | 0.00% |
| Jan. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1068 | $6.64 | 102,068.0000 | 410,315,000 | 1.04% | 0.00% |
| Jan. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 103,136.0000 | 410,315,000 | 2.59% | 0.00% |
| Jan. 15, 2024 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 10,424.0000 | 410,315,000 | 20.00% | 0.00% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3528 | $5.94 | 100,530.0000 | 412,858,000 | 3.39% | 0.00% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10200 | $0.00 | 104,058.0000 | 412,858,000 | 10.87% | 0.00% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10200 | $0.00 | 112,209.0000 | 412,858,000 | 8.33% | 0.00% |
| Nov. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12663 | $0.00 | 98,237.0000 | 412,858,000 | 14.80% | 0.00% |
| Nov. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12663 | $0.00 | 177,278.0000 | 412,858,000 | 6.67% | 0.00% |
| Nov. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4379 | $5.40 | 93,858.0000 | 412,858,000 | 4.46% | 0.00% |
| Oct. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 13,030.0000 | 412,858,000 | 16.67% | 0.00% |
| Oct. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 86,476.0000 | 412,858,000 | 3.11% | 0.00% |
| Oct. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 902 | $5.31 | 85,574.0000 | 412,858,000 | 1.04% | 0.00% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 87,398.0000 | 412,858,000 | 13.21% | 0.00% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3528 | $6.16 | 83,870.0000 | 412,858,000 | 4.04% | 0.00% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 122,409.0000 | 412,858,000 | 7.69% | 0.00% |
| Aug. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 12662 | $0.00 | 189,941.0000 | 412,858,000 | 6.25% | 0.00% |
| Aug. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 12662 | $0.00 | 81,576.0000 | 412,858,000 | 18.37% | 0.00% |
| Aug. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4379 | $8.68 | 77,197.0000 | 412,858,000 | 5.37% | 0.00% |
| July 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 902 | $7.46 | 68,914.0000 | 412,858,000 | 1.29% | 0.00% |
| July 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 69,816.0000 | 412,858,000 | 3.88% | 0.00% |
| July 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 15,636.0000 | 412,858,000 | 14.29% | 0.00% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Units | 10201 | $0.00 | 132,610.0000 | 412,858,000 | 7.14% | 0.00% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 3528 | $5.41 | 67,210.0000 | 412,858,000 | 4.99% | 0.00% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 70,738.0000 | 412,858,000 | 16.85% | 0.00% |
| May 30, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Restricted Stock Units | 202603 | $0.00 | 202,603.0000 | 412,858,000 | 9999.99% | 0.05% |
| May 30, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | A | Stock option (Right to Buy) | 276900 | $0.00 | 276,900.0000 | 412,858,000 | 9999.99% | 0.07% |
| April 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 18,242.0000 | 412,858,000 | 12.50% | 0.00% |
| April 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 61,439.0000 | 412,858,000 | 4.43% | 0.00% |
| April 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 902 | $5.95 | 60,537.0000 | 412,858,000 | 1.47% | 0.00% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 10201 | $0.00 | 142,811.0000 | 412,858,000 | 6.67% | 0.00% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 10201 | $0.00 | 62,993.0000 | 412,858,000 | 19.32% | 0.00% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 4160 | $5.50 | 58,833.0000 | 412,858,000 | 6.60% | 0.00% |
| Jan. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Restricted Stock Unit | 2606 | $0.00 | 20,848.0000 | 412,858,000 | 11.11% | 0.00% |
| Jan. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | M | Class A Common Stock | 2606 | $0.00 | 53,855.0000 | 412,858,000 | 5.08% | 0.00% |
| Jan. 15, 2023 | GoodRx Holdings, Inc. | $GDRX | Nabiey Romin | Chief Accounting Officer | F | Class A Common Stock | 1063 | $5.27 | 52,792.0000 | 412,858,000 | 1.97% | 0.00% |